Use of gellable pharmaceutical compositions in periodontology

摘要

The invention concerns the use for treating periodontitis of a fluid pharmaceutical composition for controlled release of at least one active substance comprising: a) a therapeutically efficient amount of at least an active substance; b) 3 to 55 wt. % of phospholipid; c) 16 to 72 wt. % of one or several pharmaceutically acceptable solvents; and d) 4 to 52 wt. % of at least one fatty acid. Said composition is characterised in that it has the property of being gelled instantaneously in the presence of an aqueous phase.